Research notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Through the worst of it

Helloworld
3:27pm
August 26, 2025
While HLO’s FY25 result was well down on the pcp, after a stronger than expected 2H25, it beat expectations. HLO’s outlook comments were relatively upbeat and it highlighted its strong forward bookings. New acquisitions should also underpin solid earnings growth in FY26. We have upgraded our forecasts. Given HLO’s undemanding trading multiples, improved trading conditions, and contribution from new acquisitions, we upgrade to a BUY rating. In FY26, it will be interesting to watch HLO’s next move regarding its ~17% stake in WJL.

Watching brief

Intelligent Monitoring Group
3:27pm
August 26, 2025
The FY25 result was messy considering earnings had effectively been pre-released last month at the 4C. The accounts remain unaudited as the company awaits specialist advice relating to its ability to use tax credits, though the company is confident in its tax position. While unaudited EBITDA was within the margin of error vs last disclosure ($38.4m vs $38.6m), higher depreciation saw EBITA -4% vs MorgansF. Additionally, exercise of warrants from a previous re-financing (2023) saw 18.7m shares issued (~5% dilution). The trifecta of unaudited accounts, a slight EBITA miss and dilution caused significant share price weakness today. We retain our Speculative Buy rating but reduce our target price to 85c (from 90c) on a higher share count and slightly lower earnings. FY26 earnings guidance will be provided at the AGM in November.

The road to recovery more than a 2H25 turnaround

Johns Lyng Group
3:27pm
August 26, 2025
JLG delivered a solid FY25 result reaching consensus expectations and achieving FY25 guidance, reflecting a monumental 2H25 turnaround. Group EBITDA of $126.8m (-2.2% yoy) was in line with MorgF of $126m, which included EBITDA of $118m (in line with MorgF of $118.7m), and CAT EBITDA of $8.8m (ahead of MorgF of $7.3m). FY26 guidance however reflected a different story, implying a further -130bps of BAU margin deterioration in the year ahead as a result of latent capacity in the group’s cost base (materially lower than MorgF and consensus expectations). We reduce our EBITDA forecasts by ~11-12% in FY26-FY27F reflecting JLG’s revised revenue and margin guidance. Our target price is in line with the scheme offer of A$4.00/sh, which informs our Hold rating.

Customers are liking the offer

Coles Group
3:27pm
August 26, 2025
While COL’s FY25 result was broadly in line with expectations, the company has made a stronger-than-anticipated start to FY26, particularly in its core Supermarkets division. COL’s Supermarkets offer continues to resonate with customers with strong volume growth enabling the business to successfully absorb a 30% decline in tobacco sales. Despite ongoing customer cautiousness, management said they are seeing signs of green shoots in consumer sentiment following the recent interest rate cuts. We increase FY26-28F underlying EBIT by between 2-3%. Our target price rises to $23.45 (from $20.95), reflecting upgraded earnings forecasts and increased confidence in management’s ability to execute. While we maintain our HOLD rating with a 12-month forecast TSR of 8%, we continue to view COL as a quality business with defensive attributes and structural tailwinds from population growth. We would consider adopting a more positive stance on the stock should the share price weaken.

Continuing to deliver improving profitability

Tyro Payments
3:27pm
August 26, 2025
TYR’s FY25 result was slightly below consensus expectations (-1%-2%) at revenue (A$486m) and EBITDA (A$61.5m), but more in line at NPAT (A$17.6m).  We saw this as a solid result overall, with continuing EBITDA margin improvement arguably the key positive highlight. We lift our normalised PBT forecasts by +15%/+5% over the next two years, mainly on higher EBITDA margin assumptions. We note our EPS forecasts are +15%/-26% over the same timeframe, with our FY27 forecast impacted by TYR beginning to pay tax (which is slightly earlier than we thought). Our price target rises to A$1.67 (from A$1.55). With ~40% upside to our price target (A$1.67), we maintain a BUY rating.

From transition to traction in FY26

Microba Life Sciences
3:27pm
August 26, 2025
MAP reported its FY25 result. Messier result with divestment of the research services division and a contingent liability reversal for its Invivo acquisition, but underlying result was largely in-line with expectations and sets up a solid springboard into FY26 and beyond. Key outlook commentary continues to remain, and FY26 guidance sets the scene for a strong sales period coupled with guiding for breakeven on a regional basis. Our valuation and target price moderates to A$0.29 (from A$0.31) and we retain our SPECULATIVE BUY recommendation.

Built Nanosonics tough

Nanosonics
3:27pm
August 26, 2025
FY25 result was a beat to expectations, supported by strong consumables growth and capital sales growth. Key short-term focus remains installed base growth which beat our pass-mark (>2k units), and early signs of upgrade cycle acceleration across the ageing fleet in North America. Commentary around CORIS launch remains positive and potentially conservative, with phased commercial rollout expected now in FY27 followed by broader adoption in FY28. Timing hinges on FDA 510(k) approvals which we have seen recent evidence of backlog and delays to approvals. However, we view CORIS timing arbitrary over the life-cycle of the device and particularly so with the Trophon business humming along and showing strong operating leverage. No change to positive view or valuation. Target price of A$5.50 remains.

Mixed bag, momentum fades

Ansell
3:27pm
August 26, 2025
FY25 was mixed, with softer underlying top-line results offset by in-line double-digit profit growth, supported by acquisition gains, cost outs and one-off items. Industrial margins reached record highs on new product introductions and cost savings, while Healthcare rebounded strongly as channel inventory destocking and production cuts normalised. While APIP cost savings remain on track, KBU is outperforming and pricing is being used to offset initial US tariffs, underlying earnings momentum is slowing, subsequent price increases risk dampening demand, and a multi-year digital transformation beginning in 2HFY26 could cause disruption. We have adjusted FY26-27 underlying profit up to 1.7%, with our DCF/SOTP price target increasing to A$34.64 (From A$33.38). Hold.

Pipeline building, approvals drawing closer

Imricor Medical Systems
3:27pm
August 26, 2025
IMR posted its 1H25 results which were in line with expectations. Our focus remains on regulatory and clinical progress, which we think will deliver regular news flow over the next 6 to 12 months, maintaining strong investor interest. Our key focus in the Northstar approval in the US (expected in 4Q25) and the progress of the atrial flutter trial (approval expected in 2H26). We have made no changes to forecasts or our target price. We maintain our SPECULATIVE BUY recommendation.

Animal spirits

IMDEX
3:27pm
August 25, 2025
IMD shares have performed strongly since our initiation in June-24 (+55%) as the key lead indicators for exploration have continued to firm. The strength of the exploration cycle is undoubtedly gathering pace. Further outperformance will hinge upon IMD’s ability to maintain market share (as competition intensifies), control costs and ultimately re-capture the strong operating leverage in cycles past. This will dictate whether forecasts in FY26 and beyond are too conservative. The expiry of the time-stamped core orientation tool patent next month adds another layer of uncertainty. We trim our EPS forecasts by 5-6% in each of FY26 and FY27 and stretch our valuation to ~28x FY26 adjusted PE. Our target price rises to $3.45 (from $3.20). We continue to like IMD for pure play exposure to the exploration cycle on which we remain bullish. Given recent share price strength, valuation on our current forecasts offers less upside than previously, so we’re taking a pause for breath and moving to a HOLD.

News & insights

Uncover insights from Jackson Hole: Jay Powell’s rate cut hints, Fed’s soft landing concerns, and dire demographic trends. Analysis by Morgans’ Chief Economist.


There is more to what happened at Jackson Hole than just the speech by Jay Powell.

In my talk last week ,I said that our model of the Fed funds rate stood at 3.65%. This is actually 70 basis points lower than the actual  level of 4.35%.

I also said that the Fed was successfully achieving a "soft landing" with employment growing at 1%. This was below the median level of employment growth  since 2004 of 1.6%.

Still , as I listened to Jay Powell Speak , I noted a sense of concern in his voice when he said that "The July employment report released earlier this month slowed to an average pace of only 35,000 average per month over the past three months, down from 168,000 per month during 2024. This slowdown is much larger than assessed just a month ago."

My interpretation of this is that Chair Powell may be concerned that the "soft landing " achieved by the Fed may be in danger of turning into a "hard landing". This suggested a rate cut of 25 basis points by the Fed at the next meeting on 17-18 September.

This would leave the Fed Funds rate at 4.1%. This would mean that the Fed Funds rate would still be 45 basis points higher than our model estimate of 3.65%. Hence the Fed Funds rate would remain "modestly restrictive."

Dire Demography?

Jackson Hole was actually a Fed Strategy meeting with many speakers in addition to Jay Powell.

Two speakers who followed on the  afternoon of his speech were Claudia Goldin, Professor at Harvard

and Chad Janis of Stanford Graduate Business School. They each gave foreboding presentations on the demography of developed economies.

Claudia Goldin spoke on "The Downside of Fertility".  She noted that birth rates in the Developed World are now generally  below replacement level. The Total Fertility rate is below 2 in France , the US and the UK.

It is dangerously low below 1.5 in Italy and Spain and below 1 in Korea. She observes that the age of first marriage of couples  in the US is now 7 years later than it was in the 1960's. This reduces  their child bearing years.

This paper was then followed by a discussion of it by Chad Janis of Stanford Graduate Business School. He noted that there is a profound difference between a future with a replacement rate of 2.2 kids per family , which he called  the "Expanding Cosmos"  with

•   Growing population leading to a growing number of researchers, leading to rising living standards  and Exponential growth in both living standards and population AND a replacement level of 1.9 kids per family which leads to  

•   Negative population growth , which he called "an Empty Planet " and the end of humanity

 as numbers of researchers declines and economic growth ceases.

Of course this seems all  very serious indeed .  Perhaps what this really means ,is that  if  we want to save the world , we should just relax and start having a lot more fun!!

Read more
Michael Knox, Chief Economist explains how the RBA sets interest rates to achieve its 2.5% inflation target, predicting a cash rate reduction to 3.35% by November when inflation is expected to reach 2.5%, based on a historical average real rate of 0.85%.

Today, we’re diving into how the Reserve Bank of Australia (RBA) sets interest rates as it nears its target of 2.5% inflation, and what happens when that target is reached. Back in 1898, Swedish economist Knut Wicksell  published *Money, Interest and Commodity Prices*, introducing the concept of the natural rate of interest. This is the real interest rate that maintains price stability. Unlike Wicksell’s time, modern central banks, including the RBA, focus on stabilising the rate of inflation rather than the price level itself.

In Australia, the RBA aims to keep inflation at 2.5%. To achieve this, it sets a real interest rate, known as the neutral rate, which can only be determined in practice by observing what rate stabilises inflation at 2.5%. Looking at data from January 2000, we see significant fluctuations in Australia’s real cash rate, but over the long term, the average real rate has been 0.85%. This suggests that the RBA can maintain its 2.5% inflation target with an average real cash rate of 0.85%. This is a valuable insight as the RBA approaches this target.

Australian Real Cash Rate -July 2025

As inflation nears 2.5%, we can estimate that the cash rate will settle at 2.5% (the inflation target) plus the long-term real rate of 0.85%, resulting in a cash rate of 3.35%. At the RBA meeting on Tuesday, 12 August, when the trimmed mean inflation rate for June had already  dropped to 2.7%, the RBA reduced the real cash rate to 0.9%, resulting in a cash rate of 3.6%.

We anticipate that when the trimmed mean inflation for September falls to 2.5%, as expected, the cash rate will adjust to 2.5% plus the long-term real rate of 0.85%, bringing it to 3.35%. The September quarter trimmed mean will be published at the end of October, just before the RBA’s November meeting. We expect the RBA to hold the cash rate steady at its September meeting, but when it meets in November, with the trimmed mean likely at 2.5%, the cash rate is projected to fall to 3.35%.

Australian Real Cash Rate - August 2025
Read more
Michael Knox, Chief Economist looks at what might have happened in January 2026 if the cuts in corporate tax rates in Trumps first term were not renewed and extended in the One Big Beautiful Bill

In recent weeks, a number of media commentators have criticized Donald Trump's " One big Beautiful Bill " on the basis of a statement by the Congressional Budget Office that under existing legislation the bill adds $US 3.4 trillion to the US Budget deficit. They tend not to mention that this is because the existing law assumes that all the tax cuts made in 2017 by the first Trump Administration expire at the end of this year.

Let’s us look at what might have happened in January 2026 if the cuts in US corporate tax rates in Trumps first term were not renewed and extended in the One Big Beautiful Bill.

Back in 2016 before the first Trump administration came to office in his first term, the US corporate tax rate was then 35%. In 2017 the Tax Cut and Jobs Act reduced the corporate tax rate to 21%. Because this bill was passed as a "Reconciliation Bill “, This meant it required only a simple majority of Senate votes to pass. This tax rate of 21% was due to expire in January 2026.

The One Big Beautiful Bill has made the expiring tax cuts permanent; this bill was signed into law on 4 July 2025. Now of course the same legislation also made a large number of individual tax cuts in the original 2017 bill permanent.

What would have happened if the bill had not passed. Let us construct what economists call a "Counterfactual"

Let’s just restrict ourselves to the case of what have happened in 2026 if the US corporate tax had risen to the prior rate of 35%.

This is an increase in the corporate tax rate of 14%. This increase would generate a sudden fall in US corporate after-tax earnings in January 2026 of 14%. What effect would that have on the level of the S&P 500?

The Price /Earnings Ratio of the S&P500 in July 2025 was 26.1.

Still the ten-year average Price/ Earnings Ratio for the S&P500 is only 18.99. Let’s say 19 times.

Should earnings per share have suddenly fallen by 14%, then the S&P 500 might have fallen by 14% multiplied by the short-term Price/ Earnings ratio.

This means a likely fall in the S&P500 of 37%.

As the market recovered to long term Price Earnings ratio of 19 this fall might then have ben be reduced to 27%.

Put simply, had the One Big, beautiful Bill not been passed, then in 2026 the US stock market might suddenly have fallen by 37% before then recovering to a fall of 27% .

The devastating effect on the US and indeed World economy might plausibly have caused a major recession.

On 9 June Kevin Hassert the Director of the National Economic Council said in a CBS interview with Margaret Brennan that if the bill did not pass US GDP would fall by 4% and 6-7 million Americans would lose their jobs.

The Passage of the One Big Beautiful Bill on 4 July thus avoided One Big Ugly Disaster.

Read more